JAKARTA – PT Bank Mandiri (Persero) Tbk (BMRI) is planning to conduct a share buyback worth up to IDR 1.17 trillion in April 2026.

Management said the programme is expected to strengthen stakeholder confidence in the state-owned bank’s long-term prospects and sustainable growth.

“At the same time, it will maintain a balance between market conditions and the company’s fundamentals,” management said in an official statement.

In addition, BMRI will allocate the repurchased shares for its employee stock ownership programme (MESOP), as well as for members of the board of directors and commissioners.

The company emphasised that it will not proceed with the buyback if it risks significantly reducing the number of shares in circulation to the extent that it disrupts market liquidity.

“The nominal value of shares to be repurchased will not exceed 10% of the paid-up capital,” BMRI management said in a statement on Tuesday (17/3).

The funds for the corporate action will come from BMRI’s internal cash.

According to the company’s disclosure on Tuesday (17/3), the buyback may be conducted either on-market or off-market, in stages or in a single transaction.

However, the programme must be completed no later than 12 months after approval at the upcoming General Meeting of Shareholders (GMS), scheduled for 29 April 2026.

If approved, the buyback period is expected to run from 30 April 2026 to 29 April 2027, or up to a maximum of 12 months following the GMS.

As of the second trading session on Tuesday (17/3), at 3:14 PM WIB, BMRI shares rose slightly by 0.64% to IDR 4,730 per share.

However, over the past five days, BMRI shares have declined 4.06% and fallen 10.33% over the past month. (DK/ZH)